FORM 8-K

                      SECURITIES AND EXCHANGE COMMISSION

                            Washington, D.C.  20549





                                CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


                       DATE OF REPORT:  JANUARY 17, 2002
                       (Date of earliest event reported)


                          KIMBERLY-CLARK CORPORATION
            (Exact name of registrant as specified in its charter)


     DELAWARE                            1-225             39-0394230

     (State or other jurisdiction     (Commission File    (IRS Employer
     of incorporation)                  Number)           Identification No.)


          P.O. BOX 619100, DALLAS, TEXAS                    75261-9100
          (Address of principal executive offices)          (Zip Code)


                                (972) 281-1200
             (Registrant's telephone number, including area code)

                      -----------------------------------

<PAGE>



Item  9.  Regulation FD Disclosure
----------------------------------

On January 17, 2002, Kimberly-Clark Corporation filed a Current Report on Form
8-K with the Securities and Exchange Commission in order to furnish investors
with a summary of the Company's sales and operating profit by business segment
for 1999, 2000 and the first nine months of 2001. The information furnished on
January 17, 2002 has been further reclassified with respect to the reported
operating profit of the Consumer Tissue and Business to Business Segments for
the year 1999 and for each quarter and the full year 2000. The summary
including the further reclassified information is furnished on Exhibit 99
attached hereto.

This information reflects the newly defined business segments of the Company
as a result of recent organizational changes. The new business segments are
Personal Care, Consumer Tissue and Business to Business.

The reclassifications of historical financial information are consistent with
the Company's announcement during a November 30, 2001 web-casted conference
call. Sales and operating profit of K-C Professional and Neenah Paper have
been removed from the former Tissue segment and included in the new Business
to Business segment along with the Company's Health Care, Nonwovens and
Technical Paper operations that formerly constituted the Health Care and Other
segment. The now smaller Tissue segment has been renamed Consumer Tissue. The
Personal Care segment has not changed.




                                   SIGNATURE
                                   ---------

Pursuant to the requirements  of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.





                                                     KIMBERLY-CLARK CORPORATION


Date:  January 23, 2002                        By: /s/ John W. Donehower
                                                   -----------------------------

                                                       John W. Donehower
                                                       Senior Vice President and
                                                       Chief Financial Officer

<PAGE>
                                 EXHIBIT INDEX
                                 -------------


(99)  Sales and Operating Profit by Business Segment (as reclassified) for
      1999, 2000 and the first nine months of 2001.
[{"type": "8-K", "sequence": "1", "filename": "form8k.txt", "description": "LIVE 8K DOCUMENT", "secsgml_size_bytes": 3511}]
{"company-data": {"conformed-name": "KIMBERLY CLARK CORP", "cik": "0000055785", "assigned-sic": "2621", "irs-number": "390394230", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-00225", "film-number": "02515116"}, "business-address": {"street1": "P O BOX 619100", "street2": "DFW AIRPORT STATION", "city": "DALLAS", "state": "TX", "zip": "75261-9100", "phone": "9722811200"}, "mail-address": {"street1": "351 PHELPS DRIVE", "city": "IRVING", "state": "TX", "zip": "75038"}}
FORM 8-K

                      SECURITIES AND EXCHANGE COMMISSION

                            Washington, D.C.  20549

                                CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

                       DATE OF REPORT:  JANUARY 17, 2002
                       (Date of earliest event reported)

                          KIMBERLY-CLARK CORPORATION
            (Exact name of registrant as specified in its charter)

     DELAWARE                            1-225             39-0394230

     (State or other jurisdiction     (Commission File    (IRS Employer
     of incorporation)                  Number)           Identification No.)

          P.O. BOX 619100, DALLAS, TEXAS                    75261-9100
          (Address of principal executive offices)          (Zip Code)

                                (972) 281-1200
             (Registrant's telephone number, including area code)

                      -----------------------------------
Item  9.  Regulation FD Disclosure
----------------------------------

On January 17, 2002, Kimberly-Clark Corporation filed a Current Report on Form
8-K with the Securities and Exchange Commission in order to furnish investors
with a summary of the Company's sales and operating profit by business segment
for 1999, 2000 and the first nine months of 2001. The information furnished on
January 17, 2002 has been further reclassified with respect to the reported
operating profit of the Consumer Tissue and Business to Business Segments for
the year 1999 and for each quarter and the full year 2000. The summary
including the further reclassified information is furnished on Exhibit 99
attached hereto.

This information reflects the newly defined business segments of the Company
as a result of recent organizational changes. The new business segments are
Personal Care, Consumer Tissue and Business to Business.

The reclassifications of historical financial information are consistent with
the Company's announcement during a November 30, 2001 web-casted conference
call. Sales and operating profit of K-C Professional and Neenah Paper have
been removed from the former Tissue segment and included in the new Business
to Business segment along with the Company's Health Care, Nonwovens and
Technical Paper operations that formerly constituted the Health Care and Other
segment. The now smaller Tissue segment has been renamed Consumer Tissue. The
Personal Care segment has not changed.

                                   SIGNATURE
                                   ---------

Pursuant to the requirements  of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                                     KIMBERLY-CLARK CORPORATION

Date:  January 23, 2002                        By: /s/ John W. Donehower
                                                   -----------------------------

                                                       John W. Donehower
                                                       Senior Vice President and
                                                       Chief Financial Officer
EXHIBIT INDEX
                                 -------------

(99)  Sales and Operating Profit by Business Segment (as reclassified) for
      1999, 2000 and the first nine months of 2001.